scispace - formally typeset
Open AccessJournal ArticleDOI

Interpretative strategies for lung function tests

Reads0
Chats0
TLDR
This section is written to provide guidance in interpreting pulmonary function tests (PFTs) to medical directors of hospital-based laboratories that perform PFTs, and physicians who are responsible for interpreting the results of PFTS most commonly ordered for clinical purposes.
Abstract
SERIES “ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING” Edited by V. Brusasco, R. Crapo and G. Viegi Number 5 in this Series This section is written to provide guidance in interpreting pulmonary function tests (PFTs) to medical directors of hospital-based laboratories that perform PFTs, and physicians who are responsible for interpreting the results of PFTs most commonly ordered for clinical purposes. Specifically, this section addresses the interpretation of spirometry, bronchodilator response, carbon monoxide diffusing capacity ( D L,CO) and lung volumes. The sources of variation in lung function testing and technical aspects of spirometry, lung volume measurements and D L,CO measurement have been considered in other documents published in this series of Task Force reports 1–4 and in the American Thoracic Society (ATS) interpretative strategies document 5. An interpretation begins with a review and comment on test quality. Tests that are less than optimal may still contain useful information, but interpreters should identify the problems and the direction and magnitude of the potential errors. Omitting the quality review and relying only on numerical results for clinical decision making is a common mistake, which is more easily made by those who are dependent upon computer interpretations. Once quality has been assured, the next steps involve a series of comparisons 6 that include comparisons of test results with reference values based on healthy subjects 5, comparisons with known disease or abnormal physiological patterns ( i.e. obstruction and restriction), and comparisons with self, a rather formal term for evaluating change in an individual patient. A final step in the lung function report is to answer the clinical question that prompted the test. Poor choices made during these preparatory steps increase the risk of misclassification, i.e. a falsely negative or falsely positive interpretation for a lung function abnormality or a change …

read more

Citations
More filters
Journal ArticleDOI

Standardisation of spirometry

TL;DR: This research presents a novel and scalable approach called “Standardation of LUNG FUNCTION TESTing” that combines “situational awareness” and “machine learning” to solve the challenge of integrating nanofiltration into the energy system.
Journal ArticleDOI

Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

TL;DR: Spirometric prediction equations for the 3–95-age range are now available that include appropriate age-dependent lower limits of normal for spirometric indices, which can be applied globally to different ethnic groups.
References
More filters
Journal ArticleDOI

Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy.

TL;DR: Investigation of the severity and functional consequences of weakness of the respiratory muscles in 12 patients with motor neurone disease and 19 patients with myotonic dystrophy found evidence of severe diaphragmatic weakness, while the presence of CO2 retention did not correlate well with the ventilatory response to CO2, and could not be clearly attributed to weakness.
Journal ArticleDOI

Influence of expiratory loading and hyperinflation on cardiac output during exercise.

TL;DR: EL leads to a reduction in CO, which appears to be primarily related to increases in expiratory abdominal and intrathoracic pressure, whereas ELH resulted in an improved CO, suggesting that lung inflation has little impact on cardiac function.
Journal ArticleDOI

Predictors of survival in subjects with chronic airflow limitation.

TL;DR: Current smokers had a poorer survival probability than the reference population and an increased death risk when compared with the nonsmokers in the study, and pack/years of smoking also affected survival.
Journal ArticleDOI

Historical review: the carbon monoxide diffusing capacity (DlCO) and its membrane (Dm) and red cell (Θ·Vc) components

TL;DR: The single breath carbon monoxide diffusing capacity (DLCO sb), also called the transfer factor (TLCO), was introduced by Marie and August Krogh in two papers and eventually became the method of choice in pulmonary function laboratories.
Journal ArticleDOI

Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland.

TL;DR: It is a major observation of this study that all-cause and cardiovascular mortality are significantly more often found among subjects with ventilatory impairment (independent of smoking status), and reasons for the association of ASHD mortality with impaired forced expiration are discussed.
Related Papers (5)